These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 4853169

  • 1. Metabolic bone disease. Discussion.
    Ir J Med Sci; 1974 Jul; 0(0):suppl:74-84. PubMed ID: 4853169
    [No Abstract] [Full Text] [Related]

  • 2. [Osteoarticular manifestations during liver and gastrointestinal diseases].
    Perri F, Pastore M, Annese V, Caruso N, Napolitano G, Andriulli A.
    Minerva Gastroenterol Dietol; 1994 Sep; 40(3):137-50. PubMed ID: 7948323
    [Abstract] [Full Text] [Related]

  • 3. [Intestinal osteopathies (report) (author's transl)].
    Kuhlencordt F, Kruse HP.
    Verh Dtsch Ges Pathol; 1974 Sep; 58():144-56. PubMed ID: 4460458
    [No Abstract] [Full Text] [Related]

  • 4. Bone abnormalities in gastrointestinal and hepatic disease.
    Sylvester FA.
    Rev Endocr Metab Disord; 2001 Jan; 2(1):75-80. PubMed ID: 11704981
    [No Abstract] [Full Text] [Related]

  • 5. Metabolic bone disease in gastrointestinal illness.
    Williams SE, Seidner DL.
    Gastroenterol Clin North Am; 2007 Mar; 36(1):161-90, viii. PubMed ID: 17472881
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Bone manifestations in chronic kidney diseases].
    van Amstel WJ.
    Ned Tijdschr Geneeskd; 1972 Apr 22; 116(17):693-6. PubMed ID: 5019288
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A patient with end-stage renal disease and a neck mass.
    Alspaugh JA.
    J Tenn Med Assoc; 1995 Feb 22; 88(2):60-1. PubMed ID: 7861783
    [No Abstract] [Full Text] [Related]

  • 12. Bone disease: a primer/Part I. Clinical differences among vitamin D hormone compounds.
    Goode JL.
    Nephrol News Issues; 2001 May 22; 15(6):22-3. PubMed ID: 12108997
    [No Abstract] [Full Text] [Related]

  • 13. K/DOQI guidelines released on bone metabolism and disease in CKD.
    Massry S.
    Nephrol News Issues; 2003 Nov 22; 17(12):38-41, 44. PubMed ID: 14640009
    [No Abstract] [Full Text] [Related]

  • 14. [Bone and soft tissue damage in patients with chronic renal failure during treatment by systematic hemodialysis].
    Nenov D, Kolev Z, Vicheva S.
    Urol Nefrol (Mosk); 1984 Nov 22; (6):53-6. PubMed ID: 6516077
    [No Abstract] [Full Text] [Related]

  • 15. Is there a link between erythropoietin therapy and adynamic bone disease?
    Smans KA, Van Landeghem FG, D'Haese PC, Couttenye MM, De Broe ME.
    Nephrol Dial Transplant; 1996 Jul 22; 11(7):1248-9. PubMed ID: 8672017
    [No Abstract] [Full Text] [Related]

  • 16. [Disorders of bone metabolism in gastrointestinal and hepatic diseases].
    van Daele PL, Pols HA.
    Ned Tijdschr Geneeskd; 2000 Mar 04; 144(10):462-7. PubMed ID: 10726154
    [Abstract] [Full Text] [Related]

  • 17. Azotemic renal osteodystrophy.
    Kessner DM.
    Conn Med; 1968 May 04; 32(5):374-8. PubMed ID: 5653075
    [No Abstract] [Full Text] [Related]

  • 18. Disorders of calcium and bone metabolism in chronic renal failure.
    Avioli LV.
    Mod Treat; 1970 May 04; 7(3):675-85. PubMed ID: 4920810
    [No Abstract] [Full Text] [Related]

  • 19. Consequences of chronic kidney disease--mineral and bone disorder: a progressive disease.
    Smith KR, Smelt SC.
    Nephrol Nurs J; 2009 May 04; 36(1):49-55. PubMed ID: 19271624
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.